11. Recommendations for evaluating donor eligibility using individual risk-based questions to reduce the risk of human immunodeficiency virus transmission by blood and blood products: guidance for industry Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, May 2023 Subject(s): Blood DonationBlood DonorsBlood TransfusionDonor SelectionGovernment RegulationHIV Infections -- prevention & controlMandatory TestingUnited States
12. Compliance policy regarding blood and blood component donation suitability, donor eligibility and source plasma quarantine hold requirements: guidance for industry Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, October 2023 Subject(s): Blood Banking -- standardsBlood Donation -- standardsBlood DonorsDonor Selection -- standardsGovernment RegulationGuideline AdherencePlasmaUnited States
